Targeted Medicine
Canada’s hive of innovation in medical isotopes is attracting scientists from around the world

In the high-stakes race to detect disease earlier and treat it more precisely, Canada has played a pivotal role. That role came into focus at TRIUMF, the national laboratory for particle and nuclear physics in Vancouver, where scientists developed a cyclotron-based method of producing the dominant medical isotope, technetium-99m, with a particle accelerator, expanding global capacity for nuclear-medicine diagnostics.
Today, Canada is a major force in the multibillion-dollar global medical isotopes industry. Facilities across the country produce short-lived isotopes that are attached to a targeting molecule and injected into patients. The molecules locate specific cancer cells in the body, and through imaging techniques, such as PET scans, doctors can see exactly where the cells are.
Innovation and inspiration
When the CEO of a company that develops diagnostics for rare tumours and radiotherapeutics attended a conference in Canada, a picture at an exhibit caught his eye. The image sparked a chance discussion with two delegates that later led to a promising research deal in the fight against cancer.
Pictured was a BioPETx nuclear-imaging detector—one of the world’s most advanced tools for observing living plants as they are subjected, for testing purposes, to drought, infection or insect infestation. Housed at the Fedoruk Centre at the University of Saskatchewan, the machine has proved an essential tool in an era of climate change, shedding light on crop resilience and growth.
The Fedoruk Centre
The Fedoruk Centre operates a Class II nuclear facility, producing a wide range of isotopes used in imaging and supporting research into breast, colorectal, prostate and brain cancers, melanoma and conditions such as multiple sclerosis, Parkinson’s and Alzheimer’s. Medical isotopes are also used around the world to sterilise gloves and swabs, as well as in cardiac tests, cancer scans, and other diagnostics and therapies.
The centre is one of many places in Canada where researchers and associations from across the globe collaborate with local experts, often tapping into this knowledge base through business events hosted in one of Canada’s urban hubs. It’s a hive of innovation, where academia and industry co-operate to hunt for faster ways to detect and treat a wide range of devastating diseases.
In Saskatoon, Saskatchewan, at C-BIRD (the Centre for Biologic Imaging and Research & Development), scientists are developing imaging techniques to help find effective treatments for lung cancer tumours.
The International Atomic Energy Agency works with C-BIRD and has recommended it as a resource for specialised training in radioisotope and radiopharmaceutical production for sciences from abroad.
Meetings to advance medical breakthroughs
Canada’s medical nuclear science hubs continue to grow. The Institute for Advanced Medical Isotopes—with a new cyclotron and six laboratories at TRIUMF—and the Canadian Isotope Innovations Corp. (CIIC) are expanding research and production capacity.
Various nuclear medical organisations hold their annual conferences in Canadian cities from Whistler to Montréal, drawn by the expertise based in the country. Such events can tap into Canada’s collaborative culture, advanced technology and global reach.